Alvotech (ALVOW) Non Operating Income (2022 - 2024)
Alvotech (ALVOW) reported Non Operating Income of -$287.2 million for Q4 2024, up 3.03% on a YoY basis from -$278.8 million in Q1 2024, and down 162395.19% quarter-over-quarter from -$176748.0 in Q1 2024.
Alvotech (ALVOW) Non Operating Income (2022 - 2024) Analysis & Trends
Alvotech has reported Non Operating Income for 3 years, with the latest figure at -$287.2 million in Q4 2024.
- For the quarter ending Q4 2024, Non Operating Income rose 3.03% year-over-year to -$287.2 million; the trailing twelve-month figure through Dec 2024 stood at -$583.8 million (down 11.31% YoY), and the FY2023 full-year result was -$296.2 million, down 44.34% from the prior year.
- Non Operating Income for Q4 2024 stood at -$287.2 million, down from -$176748.0 in the prior quarter.
- The five-year high for Non Operating Income was -$176748.0 in Q1 2024, with the low at -$296.2 million in Q4 2023.
- Historically, Non Operating Income has averaged -$135.3 million across 3 years, with a median of -$114.0 million in 2022.
- The largest YoY upside for Non Operating Income was 99.08% in 2023 against a maximum downside of 44.34% in 2023.
- Alvotech's Non Operating Income stood at -$205.2 million in 2022, then plunged by 44.34% to -$296.2 million in 2023, then rose by 3.03% to -$287.2 million in 2024.
- The last three Non Operating Income figures came in at -$287.2 million (Q4 2024), -$176748.0 (Q1 2024), and -$296.2 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -23.23 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 5.71 Mn |
| 10 | Alvotech | - | - | -22.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -287.21 Mn |
| Mar 31, 2024 | -176,748.00 |
| Dec 31, 2023 | -296.19 Mn |
| Mar 31, 2023 | -209,286.00 |
| Dec 31, 2022 | -205.21 Mn |
| Mar 31, 2022 | -22.87 Mn |